1. From the Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (A.S., D.B.), and the National Institute of Allergy and Infectious Diseases, Bethesda (P.K.) — both in Maryland; and the Multinational Monkeypox Outbreak Response, Centers for Disease Control and Prevention, Atlanta (J.T.B.).